3
3
2
2
6
6
4
4
1
1
6
6
5
5
9
9
2
2
1
1
2020
2011
Company (42)University (13)Research Institution (2)Hospital (1)
1 - 10 of 42
Sort by
Patent
Publication NumberUS 20200009098Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2016-10-31Publication Date2020-01-09
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods of use and of methods of manufacture of these formulations.
Patent
Publication NumberUS 20190046484Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2016-02-12Publication Date2019-02-14
The present invention provides methods and kits a) for preventing and/or treating neuroblastoma (e.g., high-risk neuroblastoma) that is linked, in part, to high levels of ODC activity and increased cellular polyamine content, b) for predicting cancer patient survival, especially cancer patients whose cancer is linked, in part, to high levels of ODC activity and increased cellular polyamine contents, and c) for selecting treatment options for such patients based on the allelic nucleotide seque…
Patent
Publication NumberBR 112018008651 A2Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2016-10-31Publication Date2018-10-30
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods of use and of methods of manufacture of these formulations.
Patent
Publication NumberCL 2018001157 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-04-30Publication Date2018-09-07
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods of use and of methods of manufacture of these formulations.
Patent
Publication NumberEP 3368029 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2016-10-31Publication Date2018-09-05
Patent
Publication NumberMX 2018005350 AFiling StatusPatent ApplicationAvailabilityUnknownFiling Date2016-10-31Publication Date2018-08-14
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods of use and of methods of manufacture of these formulations.
Patent
Publication NumberCN 108366982 AFiling StatusPatent ApplicationAvailabilityUnknownFiling Date2016-10-31Publication Date2018-08-03
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methodsof use and of methods of manufacture of these formulations.
Patent
Publication NumberIL 259009 D0Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-04-29Publication Date2018-07-31
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods of use and of methods of manufacture of these formulations.
Patent
Publication NumberKR 20180069068 AFiling StatusPatent ApplicationAvailabilityUnknownFiling Date2016-10-31Publication Date2018-06-22
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods of use and of methods of manufacture of these formulations.
We found 42 documents that match your Search
Patents: 21
Clinical Trials: 13
SEC Filings: 8

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in